BBBehzad Behnam

Behzad Behnam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Behzad Behnam has a total of 119 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • In Vitro Photoprotection and Phototoxicity of Punica granatum, Crocus sativus, and Indigofera tinctoria Extracts as Natural Sunscreen Agents

    by Payam Khazaeli, Mitra Mehrabani, Zahra Zare, Mahboobhe Kavirimanesh-Khanaman, Marzieh Sajadi-Bami, Behzad Behnam, Atefeh Ameri

  • Open Access

    Evaluating the Cytotoxic Effects of Some Chlorinated Substituted 2-Amino-3-carbonitrile Chromene Derivatives on 3T3 and MCF-7 Cell Lines

    by Mehdi Abaszadeh, Arghavan Arjomand Kermani, Ali Armin, Yasaman Abolhassani, Fatemeh Haghani, Salehe Sabouri, Bagher Amirheidari, Behzad Behnam

    Cancer remains a leading cause of death worldwide, necessitating novel therapeutic approaches. In this study we synthesized and characterized 2-amino-3-carbonitrile chromene derivatives and evaluated their cytotoxic effects on 3T3 and MCF-7 cell lines. Characterization included melting point, IR, NMR, and elemental analysis. Cytotoxicity was assessed via MTT assay, with IC50 values calculated, while apoptosis induction was confirmed by flow cytometry using annexin V/propidium iodide staining. Compounds 4f and 4h demonstrated significant cytotoxicity against breast cancer cells, with IC50 values of 4.74 and 21.97 μg/mL and selectivity indices of 3.83 and 2.80, respectively. Increased apoptotic cell populations support their pro-apoptotic potential. These findings indicate that the chromene derivatives, synthesized via a one-pot method, may serve as promising candidates for further anticancer drug development.

  • Exploring the cytotoxicity of phytochemicals: Comparative analysis of single and combination therapies in multiple cell lines

    by Fatemeh Haghani, Sorour Ashaari, Narges Ashraf Ganjooei, Behzad Behnam, Prashant Kesharwani, Amirhossein Sahebkar


  • Open Access

    Niosome as a drug delivery carrier for Sorafenib: Preparation, investigation of physicochemical properties, and in vitro effects on HepG2 cell line

    by Mohammad Amin Raeisi Estabragh, Behzad Behnam, Masoud Torkzadeh-Mahani, Abbas Pardakhty

    Purpose: Sorafenib is known as one of the oral anti-cancer drugs used in liver cancer. However, its lipophilic nature can lead to side effects, variable pharmacokinetics, and poor absorption. The use of novel drug delivery systems, such as niosomes, may help address these issues and improve the effectiveness of sorafenib. Methods: Different niosomal formulations of sorafenib were prepared. The morphology, size analysis, and physical stability were investigated. The encapsulation efficiency percent of the selected formulations was measured using the dialysis method, and the release of sorafenib was checked for four hours using the Franz diffusion cell. The cytotoxicity and in vitro effect on the HepG2 cell line was investigated using the MTT assay and flow cytometry. Results: The mean volume diameter of Span 60/ Tween 60/ cholesterol (45/45/10 mole%) niosomal formulation was 6 µm with minimal size changes and good stability over six months of storage. The encapsulation efficiency percent of this formulation was 66.40±1.11, and 61.43±1.42 percent of the drug was released within four h. In vitro release followed Higuchi kinetics. Cytotoxicity tests showed an IC50 of 7.5 µg/mL for the niosomal formulation, compared to 15.96 µg/mL for the sorafenib solution. Conclusion: Niosomes containing Span 60/ Tween 60/ cholesterol (45/45/10 mole%) are promising for loading and sustained release of sorafenib. The use of niosome as a carrier can enhance the effectiveness of sorafenib on the HepG2 cell line. This niosomal formulation of sorafenib shows potential for future studies.


  • Open Access

    Fluorescent carbon dots from cumin seeds: preparation, characterization and in vitro biocompatibility test for cell imaging application

    by Banafshe Abadi, Fatemeh Askarian, Neda Mohammadi, Behzad Behnam

    Carbon dots (CDs) are a new type of nanomaterial with great potential in bioimaging, biosensing, and drug delivery. In this study, novel CDs were prepared from cumin seeds (Cuminum cyminum L) by pyrolysis. The pyrolysis method and several extraction steps were optimized to fabricate CDs from cumin seeds. The size, structure, chemical composition, and photoluminescence properties of the CDs were characterized using a size analyzer, TEM, SEM, EDX, UV-Vis, fluorescence spectroscopy, and FTIR. The influences of the CDs on cell viability were investigated in A549, 3T3, and MCF-7 cell lines via MTT assay. The cancer cell imaging potential of the CDs was assessed using fluorescence microscopy. The results showed that the CDs with a mean diameter of 13.42 nm could be obtained through the pyrolysis of cumin seeds. The obtained CDs exhibited strong and unique fluorescence properties once they were excited at different wavelengths, particularly at 350 nm. The CDs were highly stable over time, and their fluorescence properties remained unchanged after three months. Apart from the physicochemical properties of the CD, cell viability assays showed that these CDs were non-toxic to A549, MCF-7, and 3T3 cells, over 90% of the cells were viable after 24 h, even at the highest concentration (1000 µg/ml). The CDs successfully penetrated the MCF-7 cells as revealed by fluorescent images. Taken together, the fluorescent CDs derived from cumin seeds indicated excellent and stable fluorescence properties. In addition, these CDs were highly biocompatible and could be a potential option for theragnostic applications.

  • Antidiabetic Properties of Curcumin: Insights on New Mechanisms

    by Elahe Mohammadi, Behzad Behnam, Reza Mohammadinejad, Paul C. Guest, Luis E. Simental-Mendía, Amirhossein Sahebkar

    Plant extracts have been used to treat a wide range of human diseases. Curcumin, a bioactive polyphenol derived from Curcuma longa L., exhibits therapeutic effects against diabetes while only negligible adverse effects have been observed. Antioxidant and anti-inflammatory properties of curcumin are the main and well-recognized pharmacological effects that might explain its antidiabetic effects. Additionally, curcumin may regulate novel signaling molecules and enzymes involved in the pathophysiology of diabetes, including glucagon-like peptide-1, dipeptidyl peptidase-4, glucose transporters, alpha-glycosidase, alpha-amylase, and peroxisome proliferator-activated receptor gamma (PPARγ). Recent findings from in vitro and in vivo studies on novel signaling pathways involved in the potential beneficial effects of curcumin for the treatment of diabetes are discussed in this review.


  • Carbon-based Nanomaterials and Curcumin: A Review of Biosensing Applications

    by Mohammad Mohajeri, Behzad Behnam, Aida Tasbandi, Tannaz Jamialahmadi, Amirhossein Sahebkar

    Curcumin, the main active constituent of turmeric (Curcuma longa L.), is a naturally occurring phenolic compound with a wide variety of pharmacological activities. Although it has multiple pharmaceutical properties, its bioavailability and industrial usage are hindered due to rapid hydrolysis and low water solubility. Due to the growing market of curcumin, exact determination of curcumin in trade and human biological samples is important for monitoring therapeutic actions. Different nanomaterials have been suggested for sensing curcumin; and in this case, carbon-based nanomaterials (CNMs) are one of the most outstanding developments in nanomedicine, biosensing, and regenerative medicine. There are a considerable number of reports which have shown interesting potential of CNMs-based biosensors in the sensitive and selective detection of curcumin. Therefore, this review aims to increase understanding the interaction of curcumin with CNMs in the context of biosensing.


  • Open Access

    Preparing and assessing the physiochemical properties of curcumin niosomes and evaluating their cytotoxicity in 3T3 and MCF-7 cell lines

    by Narges Ashraf Ganjooei, Mandana Ohadi, Seyyed Mohammad Amin Mostafavi, Behzad Behnam, Abbas Pardakhty

    Objective: Application of vesicular drug delivery systems has made major progress in pharmaceutical science and technology. Niosomal drug delivery is potentially efficient to improve the pharmacokinetic and pharmacological properties of many compounds. Curcumin (CUR) has several documented anticancer activities; however, it has a low bioavailability that necessitates the development of efficient delivery systems. Accordingly, different niosomal preparations were prepared and evaluated in the present study to find a suitable delivery system. Materials and Methods: Span and Tween 20, 40, 60, and 80 were employed with various concentrations of cholesterol for studying the ability to form curcumin-loaded niosomes. Multiple characterization techniques including visual evaluation, particle size analysis, stability, encapsulation efficiency (EE), and release profile were studied. Cytotoxicity of curcumin niosomes on MCF7 and 3T3 cell lines was determined using MTT assay. Results: Visual and particle size analysis indicated the formation of seven niosomal formulations in the micron size range, while the formulation consisted of Tween 40/cholesterol (50/50 M%) with 0.05% w/v CUR had an average diameter of 475 nm. The latter formulation was selected and it had EE of 78.5%. The CUR release profile showed 18.7% release over a period of 300 min. The MTT results showed that CUR incorporation significantly increased the cytotoxicity of niosomes and the extent of toxicity was higher in MCF-7 cells. Conclusion: In this study, a simple niosomal formulation was developed for CUR loading with favorable physicochemical properties. The presented niosomal curcumin had also considerable effects in cell toxicity studies, which can be suggested for future anticancer studies.